P603 Persistence of vedolizumab maintenance therapy: Findings from a Belgian registry
Volume: 14, Issue: Supplement_1, Pages: S503 - S504
Published: Jan 1, 2020
Abstract
Background Clinical trials and observational studies have demonstrated the clinical efficacy of vedolizumab (VDZ) as maintenance therapy for Crohn’s disease (CD) and ulcerative colitis (UC). This report presents long-term data on persistence of VDZ maintenance therapy in real-world clinical practice in Belgium. Methods The Belgian VDZ Registry (ENCePP EUPAS6469) enrolled 202 VDZ-treated ulcerative colitis (UC) or Crohn’s disease (CD) adult...
Paper Details
Title
P603 Persistence of vedolizumab maintenance therapy: Findings from a Belgian registry
Published Date
Jan 1, 2020
Volume
14
Issue
Supplement_1
Pages
S503 - S504
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History